A GOP congressman is claiming that the head of the National Institute on Drug Abuse (NIDA) opposes marijuana rescheduling—despite the fact that her agency officially concurred with a recommendation to implement the reform as well as the director’s repeated public comments criticizing research barriers imposed by cannabis’s current Schedule I status. While Rep. Andy Harris … Continue reading GOP Congressman Claims Top Federal Drug Official ‘Adamantly Opposes’ Marijuana Rescheduling, But Agency Endorsed FDA Recommendation